MedTrace Logo

Proteases in Patients With Prostate Cancer That Has Spread to the Bone

NCT00899665 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2014-02-11

No results posted yet for this study

Summary

RATIONALE: Collecting and storing samples of bone marrow and tissue from patients to test in the laboratory may help the study of cancer.

PURPOSE: This laboratory study is comparing proteases (enzymes that break down protein) in patients with prostate cancer that has spread to the bone with patients who do not have cancer that has spread to the bone.

Conditions

Interventions

GENETIC

fluorescence in situ hybridization

GENETIC

microarray analysis

GENETIC

molecular diagnostic method

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

PROCEDURE

biopsy

PROCEDURE

immunoscintigraphy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Barbara Ann Karmanos Cancer Institute

    lead OTHER

Principal Investigators

  • Michael L. Cher, MD · Barbara Ann Karmanos Cancer Institute

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-07-31
Primary Completion
2006-09-30
Completion
2008-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00899665 on ClinicalTrials.gov